<?xml version="1.0" encoding="UTF-8"?>
<p>Favipiravir is an experimental antiviral drug being developed by Toyama Chemical of Japan with activity against many RNA viruses, including influenza.
 <xref rid="bib56 bib57" ref-type="bibr">
  <sup>56,57</sup>
 </xref> At the time of writing, clinical trials of this drug have started in Guinea, with more than 100 patients already enrolled.
</p>
